4.7 Article

Cystathionine γ-Lyase Deficiency Exacerbates CCl4-Induced Acute Hepatitis and Fibrosis in the Mouse Liver

Journal

ANTIOXIDANTS & REDOX SIGNALING
Volume 27, Issue 3, Pages 133-149

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2016.6773

Keywords

hydrogen sulfide; carbon tetrachloride; hepatitis; liver fibrosis

Funding

  1. National Key Project [2010CB945501]
  2. Science and Technology Commission of Shanghai Municipality [16DZ2280800]

Ask authors/readers for more resources

Aims: The present study examined the role of cystathionine gamma-lyase (CSE) in carbon tetrachloride (CCl4)-induced liver damage. Results: ACSE gene knock-out and luciferase gene knock-in (KI) mouse model was constructed to study the function of CSE and to trace its expression in living status. CCl4 or lipopolysaccharide markedly downregulatedCSE expression in the liver of mice. CSE-deficient mice showed increased serum alanine aminotransferase and aspartate aminotransferase levels, and liver damage after CCl4 challenge, whereas albumin and endogenous hydrogen sulfide (H2S) levels decreased significantly. CSE knockout mice showed increased serum homocysteine levels, upregulation of inflammatory cytokines, and increased autophagy and I kappa B-alpha degradation in the liver in response toCCl(4) treatment. The increase in pro-inflammatory cytokines, including tumor necrosis factor-alpha in CSE-deficient mice after CCl4 challenge, was accompanied by a significant increase in liver tissue hydroxyproline and alpha-smooth muscle actin and histopathologic changes in the liver. However, H2S donor pretreatment effectively attenuatedmost of these imbalances. Innovation: Here, a CSE knock-out and luciferase KI mouse model was established for the first time to study the transcriptional regulation of CSE expression in real time in a non-invasive manner, providing information on the effects and potential mechanisms of CSE on CCl4-induced liver injury. Conclusion: CSE deficiency increases pro-inflammatory cytokines in the liver and exacerbates acute hepatitis and liver fibrosis by reducing H2S production from L-cysteine in the liver. The present data suggest the potential of an H2S donor for the treatment of liver diseases such as toxic hepatitis and fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available